首页 > 最新文献

Clinical Epidemiology最新文献

英文 中文
Causes of Excess Mortality in Diabetes Patients Without Coronary Artery Disease: A Cohort Study Revealing Endocrinologic Contributions. 无冠状动脉疾病的糖尿病患者死亡率过高的原因:揭示内分泌因素的队列研究
IF 3.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-09-03 eCollection Date: 2024-01-01 DOI: 10.2147/CLEP.S463363
Guilian Birindwa, Michael Maeng, Pernille Gro Thrane, Christine Gyldenkerne, Reimar Wernich Thomsen, Kevin Kris Warnakula Olesen

Background: Diabetes mellitus (DM) patients without coronary artery disease (CAD) have a higher all-cause mortality rate than patients with neither DM nor CAD. We examined cause-specific death of DM patients with and without CAD.

Methods: We conducted a cohort study of all patients who underwent CAG in Western Denmark between 2003 and 2016. Using Danish health registries, patients were followed for a maximum of 10 years and stratified according to their DM and CAD status. Outcomes included all-cause-, cancer-, circulatory-, and endocrinologic death. Ten-year cumulative risks were computed as well as adjusted and unadjusted hazard ratios (aHR and HR).

Results: A total of 132,432 patients (28,524 deaths, median follow-up of 6.2 years) were included. Compared to patients with neither DM nor CAD, DM patients without CAD had a higher 10-year risk of all-cause death (27.9% versus 19.7%, aHR 1.43 [95% CI 1.35-1.52]), cancer death (7.2% versus 5.4%, aHR 1.29 [95% CI 1.15-1.46]), circulatory death (9.1% versus 6.9%, aHR 1.35 [95% CI 1.22-1.49]), and endocrinologic death (3.9% versus 0.3%, aHR 14.02 [95% CI 10.95-17.95]). Among endocrinologic deaths, 87% were due to classical complications of DM, such as diabetic nephropathy and ketoacidosis, in DM patients without CAD.

Conclusion: Diabetes patients without CAD exhibit a higher risk of all-cause mortality, driven primarily by elevated rates of cancer, circulatory, and endocrinologic deaths, particularly related to diabetic microvascular complications.

背景:无冠状动脉疾病(CAD)的糖尿病(DM)患者的全因死亡率高于既无DM也无CAD的患者。我们研究了患有和未患有冠状动脉疾病的糖尿病患者的特定死因:我们对 2003 年至 2016 年期间在丹麦西部接受 CAG 的所有患者进行了一项队列研究。通过丹麦健康登记处,我们对患者进行了最长达 10 年的随访,并根据他们的 DM 和 CAD 状态进行了分层。结果包括全因死亡、癌症死亡、循环系统死亡和内分泌死亡。研究人员计算了十年累积风险以及调整和未调整的危险比(aHR 和 HR):共纳入 132432 例患者(死亡 28524 例,中位随访时间为 6.2 年)。与既没有糖尿病也没有冠状动脉粥样硬化的患者相比,没有冠状动脉粥样硬化的糖尿病患者的全因死亡(27.9% 对 19.7%,aHR 1.43 [95% CI 1.35-1.52])、癌症死亡(7.2% 对 5.4%,aHR 1.29 [95% CI 1.15-1.46])、循环系统死亡(9.1% 对 6.9%,aHR 1.35 [95% CI 1.22-1.49])和内分泌死亡(3.9% 对 0.3%,aHR 14.02 [95% CI 10.95-17.95])。在内分泌死亡病例中,87%是由于糖尿病肾病和酮症酸中毒等传统的糖尿病并发症造成的,而无 CAD 的糖尿病患者则是由于糖尿病肾病和酮症酸中毒造成的:结论:无 CAD 的糖尿病患者全因死亡的风险较高,主要原因是癌症、循环系统和内分泌死亡的比例升高,尤其是与糖尿病微血管并发症有关的死亡。
{"title":"Causes of Excess Mortality in Diabetes Patients Without Coronary Artery Disease: A Cohort Study Revealing Endocrinologic Contributions.","authors":"Guilian Birindwa, Michael Maeng, Pernille Gro Thrane, Christine Gyldenkerne, Reimar Wernich Thomsen, Kevin Kris Warnakula Olesen","doi":"10.2147/CLEP.S463363","DOIUrl":"10.2147/CLEP.S463363","url":null,"abstract":"<p><strong>Background: </strong>Diabetes mellitus (DM) patients without coronary artery disease (CAD) have a higher all-cause mortality rate than patients with neither DM nor CAD. We examined cause-specific death of DM patients with and without CAD.</p><p><strong>Methods: </strong>We conducted a cohort study of all patients who underwent CAG in Western Denmark between 2003 and 2016. Using Danish health registries, patients were followed for a maximum of 10 years and stratified according to their DM and CAD status. Outcomes included all-cause-, cancer-, circulatory-, and endocrinologic death. Ten-year cumulative risks were computed as well as adjusted and unadjusted hazard ratios (aHR and HR).</p><p><strong>Results: </strong>A total of 132,432 patients (28,524 deaths, median follow-up of 6.2 years) were included. Compared to patients with neither DM nor CAD, DM patients without CAD had a higher 10-year risk of all-cause death (27.9% versus 19.7%, aHR 1.43 [95% CI 1.35-1.52]), cancer death (7.2% versus 5.4%, aHR 1.29 [95% CI 1.15-1.46]), circulatory death (9.1% versus 6.9%, aHR 1.35 [95% CI 1.22-1.49]), and endocrinologic death (3.9% versus 0.3%, aHR 14.02 [95% CI 10.95-17.95]). Among endocrinologic deaths, 87% were due to classical complications of DM, such as diabetic nephropathy and ketoacidosis, in DM patients without CAD.</p><p><strong>Conclusion: </strong>Diabetes patients without CAD exhibit a higher risk of all-cause mortality, driven primarily by elevated rates of cancer, circulatory, and endocrinologic deaths, particularly related to diabetic microvascular complications.</p>","PeriodicalId":10362,"journal":{"name":"Clinical Epidemiology","volume":"16 ","pages":"571-585"},"PeriodicalIF":3.4,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11380490/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142153285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obituary – Anders Ekbom 讣告 - 安德斯-埃克博姆
IF 3.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-30 DOI: 10.2147/clep.s490837
Jonas F Ludvigsson, Johan Askling, Sven Cnattingius, Per Hall, Lars Klareskog, Olof Nyren, John A Baron, Henrik Toft Sørensen
{"title":"Obituary – Anders Ekbom","authors":"Jonas F Ludvigsson, Johan Askling, Sven Cnattingius, Per Hall, Lars Klareskog, Olof Nyren, John A Baron, Henrik Toft Sørensen","doi":"10.2147/clep.s490837","DOIUrl":"https://doi.org/10.2147/clep.s490837","url":null,"abstract":"<strong>","PeriodicalId":10362,"journal":{"name":"Clinical Epidemiology","volume":"21 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142203748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of Invasive Candidiasis. 侵袭性念珠菌病的流行病学。
IF 3.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-28 eCollection Date: 2024-01-01 DOI: 10.2147/CLEP.S459600
Derek J Bays, Emily N Jenkins, Meghan Lyman, Tom Chiller, Nora Strong, Luis Ostrosky-Zeichner, Martin Hoenigl, Peter G Pappas, George R Thompson Iii

Invasive candidiasis (IC) is an increasingly prevalent, costly, and potentially fatal infection brought on by the opportunistic yeast, Candida. Previously, IC has predominantly been caused by C. albicans which is often drug susceptible. There has been a global trend towards decreasing rates of infection secondary to C. albicans and a rise in non-albicans species with a corresponding increase in drug resistance creating treatment challenges. With advances in management of malignancies, there has also been an increase in the population at risk from IC along with a corresponding increase in incidence of breakthrough IC infections. Additionally, the emergence of C. auris creates many challenges in management and prevention due to drug resistance and the organism's ability to transmit rapidly in the healthcare setting. While the development of novel antifungals is encouraging for future management, understanding the changing epidemiology of IC is a vital step in future management and prevention.

侵袭性念珠菌病(IC)是由机会性酵母菌白色念珠菌引起的一种日益流行、代价高昂且可能致命的感染。以前,IC 主要由白色念珠菌引起,而白色念珠菌通常对药物敏感。全球趋势是白念珠菌继发感染率下降,非白念珠菌感染率上升,耐药性也相应增加,这给治疗带来了挑战。随着恶性肿瘤治疗的进步,IC 的高危人群也在增加,突破性 IC 感染的发病率也相应增加。此外,由于耐药性和该病菌在医疗环境中的快速传播能力,法氏囊菌的出现给管理和预防带来了许多挑战。新型抗真菌药物的开发为未来的管理带来了鼓舞,而了解不断变化的 IC 流行病学则是未来管理和预防的重要一步。
{"title":"Epidemiology of Invasive Candidiasis.","authors":"Derek J Bays, Emily N Jenkins, Meghan Lyman, Tom Chiller, Nora Strong, Luis Ostrosky-Zeichner, Martin Hoenigl, Peter G Pappas, George R Thompson Iii","doi":"10.2147/CLEP.S459600","DOIUrl":"10.2147/CLEP.S459600","url":null,"abstract":"<p><p>Invasive candidiasis (IC) is an increasingly prevalent, costly, and potentially fatal infection brought on by the opportunistic yeast, <i>Candida</i>. Previously, IC has predominantly been caused by <i>C. albicans</i> which is often drug susceptible. There has been a global trend towards decreasing rates of infection secondary to <i>C. albicans</i> and a rise in non-<i>albicans</i> species with a corresponding increase in drug resistance creating treatment challenges. With advances in management of malignancies, there has also been an increase in the population at risk from IC along with a corresponding increase in incidence of breakthrough IC infections. Additionally, the emergence of <i>C. auris</i> creates many challenges in management and prevention due to drug resistance and the organism's ability to transmit rapidly in the healthcare setting. While the development of novel antifungals is encouraging for future management, understanding the changing epidemiology of IC is a vital step in future management and prevention.</p>","PeriodicalId":10362,"journal":{"name":"Clinical Epidemiology","volume":"16 ","pages":"549-566"},"PeriodicalIF":3.4,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366240/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142105018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Safety Climate in Danish Primary Care: Adaption and Validation of the Danish Safety Attitudes Questionnaire (SAQ-DK-PRIM). 丹麦基层医疗机构的患者安全氛围:丹麦安全态度问卷(SAQ-DK-PRIM)的改编与验证。
IF 3.4 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-27 eCollection Date: 2024-01-01 DOI: 10.2147/CLEP.S470111
Marie Haase Juhl, Anne Estrup Olesen, Ellen Tveter Deilkås, Niels Henrik Bruun, Kirsten Høgh Obling, Nikoline Rytter, Maya Damgaard Larsen, Solvejg Kristensen

Background: A lack of instruments to assess patient safety climate within primary care exists. The objectives of this study were as follows: 1) To adapt the Danish hospital version of the Safety Attitudes Questionnaire (SAQ-DK) for use in primary care; 2) Test the internal consistency and the construct validity of this version; 3) Present benchmark data; and 4) Analyze variance.

Methods: The SAQ-DK was adapted for use in Danish primary care settings (SAQ-DK-PRIM) and distributed to healthcare staff members from nursing homes (N = 11), homecare units (N = 4) and healthcare units (N = 2), within the municipality of Aarhus, Central Denmark Region, Denmark. Face- and content validity were assessed. The construct validity was evaluated by a set of goodness-of-fit indices. The internal reliability was evaluated using the item-rest correlations, the inter-item correlations, and Cronbach's alpha (α).

Results: The adaptation process resulted in a questionnaire of 10 items. Eight hundred and thirty healthcare staffs participated (78% of the eligible respondents). In total 586 (70.6%) responses were complete and were included in the analysis. Goodness-of-fit indices from the confirmatory factor analysis showed: Chi2=46.90CFI=0.97, RMSEA = 0.063 (90% CI: 0.044-0.084), Probability RMSEA (p close)=0.12. Internal reliability was high (Cronbach's α=0.76). Proportions of participants with a positive attitude was 41.1% and did not differ between the healthcare services. Scale mean score was 70.19 (SD: 18.05) and differed between healthcare services. The safety climate scale scores did not vary according to healthcare service type. ICC was 0.68% indicating no clustering of scores by healthcare service type.

Conclusion: Considering the questionnaire's applicability, short length, strengthened focus on one area of interest and validity, the SAQ-DK-PRIM can serve as a valuable tool for measuring patient safety climate within primary care settings in Denmark.

背景:目前缺乏评估基层医疗机构患者安全氛围的工具。本研究的目标如下1)将丹麦医院版的安全态度问卷(SAQ-DK)改编用于基层医疗机构;2)测试该版本的内部一致性和结构效度;3)提供基准数据;4)分析差异:对 SAQ-DK 进行了改编,以便在丹麦初级医疗机构中使用(SAQ-DK-PRIM),并分发给丹麦中部丹麦大区奥胡斯市的疗养院(11 人)、家庭护理单位(4 人)和医疗保健单位(2 人)的医护人员。对表面效度和内容效度进行了评估。通过一组拟合优度指数评估了结构效度。内部信度采用项目间相关性、项目间相关性和克朗巴赫α(α)进行评估:结果:经过改编,问卷共包含 10 个项目。830 名医护人员参与了问卷调查(占合格受访者的 78%)。共有 586 份(70.6%)答卷完整并纳入分析。确认性因素分析的拟合优度指数显示Chi2=46.90CFI=0.97,RMSEA=0.063(90% CI:0.044-0.084),概率 RMSEA(p close)=0.12。内部信度很高(Cronbach's α=0.76)。持积极态度的参与者比例为 41.1%,各医疗服务机构之间无差异。量表平均分为 70.19 分(标准差:18.05),各医疗服务机构之间存在差异。安全气氛量表的得分不因医疗服务类型而异。ICC为0.68%,表明各医疗服务类型的得分没有聚类:考虑到问卷的适用性、简短性、对某一关注领域的强化关注以及有效性,SAQ-DK-PRIM 可作为测量丹麦初级医疗机构中患者安全氛围的重要工具。
{"title":"Patient Safety Climate in Danish Primary Care: Adaption and Validation of the Danish Safety Attitudes Questionnaire (SAQ-DK-PRIM).","authors":"Marie Haase Juhl, Anne Estrup Olesen, Ellen Tveter Deilkås, Niels Henrik Bruun, Kirsten Høgh Obling, Nikoline Rytter, Maya Damgaard Larsen, Solvejg Kristensen","doi":"10.2147/CLEP.S470111","DOIUrl":"10.2147/CLEP.S470111","url":null,"abstract":"<p><strong>Background: </strong>A lack of instruments to assess patient safety climate within primary care exists. The objectives of this study were as follows: 1) To adapt the Danish hospital version of the Safety Attitudes Questionnaire (SAQ-DK) for use in primary care; 2) Test the internal consistency and the construct validity of this version; 3) Present benchmark data; and 4) Analyze variance.</p><p><strong>Methods: </strong>The SAQ-DK was adapted for use in Danish primary care settings (SAQ-DK-PRIM) and distributed to healthcare staff members from nursing homes (N = 11), homecare units (N = 4) and healthcare units (N = 2), within the municipality of Aarhus, Central Denmark Region, Denmark. Face- and content validity were assessed. The construct validity was evaluated by a set of goodness-of-fit indices. The internal reliability was evaluated using the item-rest correlations, the inter-item correlations, and Cronbach's alpha (α).</p><p><strong>Results: </strong>The adaptation process resulted in a questionnaire of 10 items. Eight hundred and thirty healthcare staffs participated (78% of the eligible respondents). In total 586 (70.6%) responses were complete and were included in the analysis. Goodness-of-fit indices from the confirmatory factor analysis showed: Chi<sup>2</sup>=46.90CFI=0.97, RMSEA = 0.063 (90% CI: 0.044-0.084), Probability RMSEA (p close)=0.12. Internal reliability was high (Cronbach's α=0.76). Proportions of participants with a positive attitude was 41.1% and did not differ between the healthcare services. Scale mean score was 70.19 (SD: 18.05) and differed between healthcare services. The safety climate scale scores did not vary according to healthcare service type. ICC was 0.68% indicating no clustering of scores by healthcare service type.</p><p><strong>Conclusion: </strong>Considering the questionnaire's applicability, short length, strengthened focus on one area of interest and validity, the SAQ-DK-PRIM can serve as a valuable tool for measuring patient safety climate within primary care settings in Denmark.</p>","PeriodicalId":10362,"journal":{"name":"Clinical Epidemiology","volume":"16 ","pages":"533-547"},"PeriodicalIF":3.4,"publicationDate":"2024-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11365490/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142105019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Validation of the Swedish Colorectal Cancer Register – With Focus on Histopathology, Complications and Recurrences 瑞典结直肠癌登记册验证--重点关注组织病理学、并发症和复发情况
IF 3.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-08-09 DOI: 10.2147/clep.s466029
Örvar Arnarson, Peter Moberger, Filip Sköldberg, Kenneth Smedh, Helgi Birgisson, Ingvar Syk
Background: There is an urgent need to evaluate the quality of healthcare systems to improve and deliver high-quality care. Clinical registries have become important platforms for performance measurements, improvements, and clinical research. Hence, the quality of data in registries is crucial. This study aimed to assess the validity of data in the Swedish Colorectal Cancer Register (SCRCR).
Methods: Seven hundred patients from 12 hospitals were randomly selected and proportionally distributed among three different hospital categories in Sweden using two-stage cluster sampling. Validity was assessed by re-abstracting data from the medical files of patients reported to the SCRCR in 2015. Data on histopathology, postoperative complications, and a 3-year follow-up were selected for validation. Re-abstracted data were defined as source data, and validity was defined as the proportion of cases in the SRCRC dataset that agreed with the source data. Validity was expressed as the percentage of exact agreement of non-missing data in both data sets, and Cohen´s kappa coefficient (κ) was used to measure the strength of the agreement.
Results: The median agreement of the categorical histopathology variables was 93.4% (κ = 0.83). The general postoperative complication variable showed substantial agreement (84.3%, κ = 0.61). Likewise, the variable for overall cancer recurrence showed an almost perfect agreement (95.7%, κ = 0.86), whereas specific variables for local recurrence and distant recurrence displayed only moderate and fair agreement (85.9% and 89.1%, κ = 0.58 and 0.34, respectively).
Conclusion: Validation of the SCRCR data showed high validity of pathology data and recurrence rates, whereas detailed data on recurrence were not as good. Data on postoperative complications were less reliable, although the incidence and Clavien–Dindo grading of severe complications (grade 3b or higher) were reliable.

背景:目前迫切需要对医疗系统的质量进行评估,以改进和提供高质量的医疗服务。临床登记已成为绩效衡量、改进和临床研究的重要平台。因此,登记数据的质量至关重要。本研究旨在评估瑞典结直肠癌登记处(SCRCR)数据的有效性:方法:采用两阶段聚类抽样法随机抽取了瑞典 12 家医院的 700 名患者,并按比例分配到三个不同的医院类别中。通过重新抽取2015年向SCRCR报告的患者医疗档案中的数据来评估有效性。我们选择了组织病理学、术后并发症和 3 年随访数据进行验证。重新摘录的数据被定义为源数据,有效性被定义为SRCRC数据集中与源数据一致的病例比例。有效性表示为两个数据集中非遗漏数据的完全一致百分比,科恩卡帕系数(κ)用于衡量一致性的强度:结果:分类组织病理学变量的中位一致性为 93.4%(κ = 0.83)。一般术后并发症变量显示出很大的一致性(84.3%,κ = 0.61)。同样,总体癌症复发变量几乎完全一致(95.7%,κ = 0.86),而局部复发和远处复发的特定变量仅显示出中等和一般的一致性(分别为85.9%和89.1%,κ = 0.58和0.34):SCRCR数据的验证结果表明,病理数据和复发率的有效性较高,而复发的详细数据则不尽如人意。术后并发症数据的可靠性较低,但严重并发症(3b 级或以上)的发生率和 Clavien-Dindo 分级是可靠的。
{"title":"A Validation of the Swedish Colorectal Cancer Register – With Focus on Histopathology, Complications and Recurrences","authors":"Örvar Arnarson, Peter Moberger, Filip Sköldberg, Kenneth Smedh, Helgi Birgisson, Ingvar Syk","doi":"10.2147/clep.s466029","DOIUrl":"https://doi.org/10.2147/clep.s466029","url":null,"abstract":"<strong>Background:</strong> There is an urgent need to evaluate the quality of healthcare systems to improve and deliver high-quality care. Clinical registries have become important platforms for performance measurements, improvements, and clinical research. Hence, the quality of data in registries is crucial. This study aimed to assess the validity of data in the Swedish Colorectal Cancer Register (SCRCR).<br/><strong>Methods:</strong> Seven hundred patients from 12 hospitals were randomly selected and proportionally distributed among three different hospital categories in Sweden using two-stage cluster sampling. Validity was assessed by re-abstracting data from the medical files of patients reported to the SCRCR in 2015. Data on histopathology, postoperative complications, and a 3-year follow-up were selected for validation. Re-abstracted data were defined as source data, and validity was defined as the proportion of cases in the SRCRC dataset that agreed with the source data. Validity was expressed as the percentage of exact agreement of non-missing data in both data sets, and Cohen´s kappa coefficient (κ) was used to measure the strength of the agreement.<br/><strong>Results:</strong> The median agreement of the categorical histopathology variables was 93.4% (κ = 0.83). The general postoperative complication variable showed substantial agreement (84.3%, κ = 0.61). Likewise, the variable for overall cancer recurrence showed an almost perfect agreement (95.7%, κ = 0.86), whereas specific variables for local recurrence and distant recurrence displayed only moderate and fair agreement (85.9% and 89.1%, κ = 0.58 and 0.34, respectively).<br/><strong>Conclusion:</strong> Validation of the SCRCR data showed high validity of pathology data and recurrence rates, whereas detailed data on recurrence were not as good. Data on postoperative complications were less reliable, although the incidence and Clavien–Dindo grading of severe complications (grade 3b or higher) were reliable.<br/><br/>","PeriodicalId":10362,"journal":{"name":"Clinical Epidemiology","volume":"41 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141936949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergency Call versus General Practitioner Requested Ambulances – Patient Mortality, Disease Severity and Pattern 紧急呼叫救护车与全科医生请求救护车--患者死亡率、疾病严重程度和模式
IF 3.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-07-30 DOI: 10.2147/clep.s469430
Morten Breinholt Søvsø, Rasmine Birch Haurum, Trine Hagelskær Ebbesen, Ann Øster Rasmussen, Logan Morgan Ward, Mads Lause Mogensen, Erika Frischknecht Christensen, Tim Alex Lindskou
Introduction: Ambulance requests by general practitioners for primary care patients (GP-requested) are often omitted in studies on increased demand within emergency care but may comprise a substantial patient group. We aimed to assess acute severity, intensive care unit (ICU) admission, and diagnostic pattern, including comorbidity, and mortality among GP-requested ambulance patients, compared to emergency call ambulance patients. Our hypothesis was that emergency call patients had more severe health issues than GP-requested ambulance patients.
Methods: Historic population-based cohort study of ambulance patients in the North Denmark Region, 2016– 2020. Hospital contact data including diagnoses, ambulance data, vital signs and vital status was linked using each patient’s unique identification number. Primary outcome measure was mortality within 1, 7, and 30 days. Secondary outcomes were disease severity expressed as modified National Early Warning Score (NEWS2), and ICU admission. Admission status and hospital diagnostic pattern, including comorbidity were described and compared.
Results: We included 255,487 patients. GP-requested patients (N = 119,361, 46.7%) were older (median years [IQR] 73 [58– 83] versus 61 [37– 76]) and more had moderate/severe comorbidity (11.9%, N = 13,806 versus 4.9%, N = 6145) than the emergency call patients. Prehospital mNEWS2 median scores were lower for GP-requested patients. For both groups, mNEWS2 was highest among patients aged 66+. GP-requested patients had higher 30-day mortality (9.0% (95% CI: 8.8– 9.2), N = 8996) than emergency call patients (5.2% (95% CI: 5.1– 5.4), N = 6727). Circulatory (12.0%, 11,695/97,112) and respiratory diseases (11.6%, 11,219/97,112) were more frequent among GP-requested patients than emergency call patients ((10.7%, 12,640/118,102) and (5.8%, 6858/118,102)). The highest number of deaths was found for health issues ‘circulatory diseases’ in the emergency call group and ‘other factors’ followed by “respiratory diseases” in the GP-requested group.
Conclusion: GP-requested patients constituted nearly half of the EMS volume, they were older, with more comorbidity, had serious conditions with substantial acute severity, and a higher 30-day mortality than emergency call patients.

Keywords: emergency medical services, mortality, diagnoses, early warning scores, after-hours care, primary healthcare, general practitioners
导言:在有关急诊需求增加的研究中,全科医生为初级保健患者申请救护车(GP-requested)的情况经常被忽略,但这可能是一个庞大的患者群体。我们旨在评估全科医生请求的救护车患者与紧急呼叫救护车患者的急性病严重程度、重症监护室(ICU)入院情况、诊断模式(包括合并症)和死亡率。我们的假设是,紧急呼叫患者的健康问题比全科医生请求的救护车患者更严重。方法:对北丹麦地区的救护车患者进行基于人群的历史性队列研究,时间为2016-2020年。医院联系数据(包括诊断、救护车数据、生命体征和生命状态)与每位患者的唯一识别码相关联。主要结果是 1 天、7 天和 30 天内的死亡率。次要结果是疾病严重程度(以修改后的全国早期预警评分(NEWS2)表示)和入住重症监护室情况。对入院情况和医院诊断模式(包括合并症)进行了描述和比较:我们纳入了 255487 名患者。与急诊呼叫患者相比,全科医生请求的患者(N = 119,361, 46.7%)年龄更大(中位年龄 [IQR] 73 [58- 83] 对 61 [37- 76]),中度/重度合并症患者更多(11.9%, N = 13,806 对 4.9%, N = 6145)。院前 mNEWS2 中位数得分在全科医生要求的患者中较低。两组患者中,66岁以上患者的mNEWS2得分最高。全科医生申请患者的 30 天死亡率(9.0% (95% CI: 8.8- 9.2), N = 8996)高于急诊呼叫患者(5.2% (95% CI: 5.1- 5.4), N = 6727)。循环系统疾病(12.0%,11,695/97,112)和呼吸系统疾病(11.6%,11,219/97,112)在全科医生申请患者中的发病率高于急诊呼叫患者((10.7%,12,640/118,102)和(5.8%,6858/118,102))。在紧急呼叫组中,死亡人数最多的健康问题是 "循环系统疾病",在全科医生请求组中,死亡人数最多的健康问题是 "其他因素",其次是 "呼吸系统疾病":全科医生请求的患者占急诊医疗服务量的近一半,他们年龄更大、合并症更多,病情严重,急性期更长,30 天死亡率高于急诊呼叫患者。 关键词:急诊医疗服务;死亡率;诊断;预警评分;下班后护理;初级医疗保健;全科医生
{"title":"Emergency Call versus General Practitioner Requested Ambulances – Patient Mortality, Disease Severity and Pattern","authors":"Morten Breinholt Søvsø, Rasmine Birch Haurum, Trine Hagelskær Ebbesen, Ann Øster Rasmussen, Logan Morgan Ward, Mads Lause Mogensen, Erika Frischknecht Christensen, Tim Alex Lindskou","doi":"10.2147/clep.s469430","DOIUrl":"https://doi.org/10.2147/clep.s469430","url":null,"abstract":"<strong>Introduction:</strong> Ambulance requests by general practitioners for primary care patients (GP-requested) are often omitted in studies on increased demand within emergency care but may comprise a substantial patient group. We aimed to assess acute severity, intensive care unit (ICU) admission, and diagnostic pattern, including comorbidity, and mortality among GP-requested ambulance patients, compared to emergency call ambulance patients. Our hypothesis was that emergency call patients had more severe health issues than GP-requested ambulance patients.<br/><strong>Methods:</strong> Historic population-based cohort study of ambulance patients in the North Denmark Region, 2016– 2020. Hospital contact data including diagnoses, ambulance data, vital signs and vital status was linked using each patient’s unique identification number. Primary outcome measure was mortality within 1, 7, and 30 days. Secondary outcomes were disease severity expressed as modified National Early Warning Score (NEWS2), and ICU admission. Admission status and hospital diagnostic pattern, including comorbidity were described and compared.<br/><strong>Results:</strong> We included 255,487 patients. GP-requested patients (N = 119,361, 46.7%) were older (median years [IQR] 73 [58– 83] versus 61 [37– 76]) and more had moderate/severe comorbidity (11.9%, N = 13,806 versus 4.9%, N = 6145) than the emergency call patients. Prehospital mNEWS2 median scores were lower for GP-requested patients. For both groups, mNEWS2 was highest among patients aged 66+. GP-requested patients had higher 30-day mortality (9.0% (95% CI: 8.8– 9.2), N = 8996) than emergency call patients (5.2% (95% CI: 5.1– 5.4), N = 6727). Circulatory (12.0%, 11,695/97,112) and respiratory diseases (11.6%, 11,219/97,112) were more frequent among GP-requested patients than emergency call patients ((10.7%, 12,640/118,102) and (5.8%, 6858/118,102)). The highest number of deaths was found for health issues ‘circulatory diseases’ in the emergency call group and ‘other factors’ followed by “respiratory diseases” in the GP-requested group.<br/><strong>Conclusion:</strong> GP-requested patients constituted nearly half of the EMS volume, they were older, with more comorbidity, had serious conditions with substantial acute severity, and a higher 30-day mortality than emergency call patients.<br/><br/><strong>Keywords:</strong> emergency medical services, mortality, diagnoses, early warning scores, after-hours care, primary healthcare, general practitioners<br/>","PeriodicalId":10362,"journal":{"name":"Clinical Epidemiology","volume":"212 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141869191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Confounding and Negative Control Methods in Observational Study of SARS-CoV-2 Vaccine Effectiveness: A Nationwide, Population-Based Danish Health Registry Study SARS-CoV-2 疫苗有效性观察研究中的混杂因素和阴性对照方法:基于丹麦全国人口的健康登记研究
IF 3.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-07-25 DOI: 10.2147/clep.s468572
Niels Obel, Matthew P Fox, Malte M Tetens, Lars Pedersen, Tyra Grove Krause, Henrik Ullum, Henrik Toft Sørensen
<strong>Background:</strong> Observational studies of SARS-CoV-2 vaccine effectiveness are prone to confounding, which can be illustrated using negative control methods.<br/><strong>Methods:</strong> Nationwide population-based cohort study including two cohorts of Danish residents 60– 90 years of age matched 1:1 on age and sex: A vaccinated and a non-vaccinated cohort, including 61052 SARS-CoV-2 vaccinated individuals between 1 March and 1 July 2021 and 61052 individuals not vaccinated preceding 1 July 2021. From these two cohorts, we constructed negative control cohorts of individuals diagnosed with SARS-CoV-2 infection or acute myocardial infarction, stroke, cancer, low energy fracture, or head-trauma. Outcomes were SARS-CoV-2 infection, negative control outcomes (eg, mammography, prostate biopsy, operation for cataract, malignant melanoma, examination of eye and ear), and death. We used Cox regression to calculate adjusted incidence and mortality rate ratios (aIRR and aMRR).<br/><strong>Results:</strong> Risks of SARS-CoV2 infection and all negative control outcomes were elevated in the vaccinated population, ranging from an aIRR of 1.15 (95% CI: 1.09– 1.21) for eye examinations to 3.05 (95% CI: 2.24– 4.14) for malignant melanoma. Conversely, the risk of death in the SARS-CoV-2 infected cohort and in all negative control cohorts was lower in vaccinated individuals, ranging from an aMRR of 0.23 (95% CI: 0.19– 0.26) after SARS-CoV-2 infection to 0.50 (95% CI: 0.37– 0.67) after stroke.<br/><strong>Conclusion:</strong> Our findings indicate that observational studies of SARS-CoV-2 vaccine effectiveness may be subject to substantial confounding. Therefore, randomized trials are essential to establish vaccine efficacy after the emergence of new SARS-CoV-2 variants and the rollout of multiple booster vaccines.<br/><br/><strong>Plain Language Summary:</strong> <strong>Why was this study done</strong>: After the emergence of new SARS-CoV-2 variants and the rollout of multiple booster SARS-CoV-2 vaccines, the impact of vaccination on risk of SARS-CoV-2 infection and death after the infection has mainly been explored in observational studies. We used negative control methods to investigate whether confounding affects the results of observational SARS-CoV-2 vaccine effectiveness studies.<br/><strong>Findings</strong>: We used Danish registry data obtained during the SARS-CoV-2 vaccine roll-out to conduct a nationwide, matched population-based cohort study of Danish residents 60– 90 years in which we compared vaccinated individuals with non-vaccinated individuals. Compared with unvaccinated individuals, vaccinated individuals had increased risks of SARS-CoV2 infection but also had increased risks of all negative control outcomes (mammography, prostate biopsy, operation for cataract, malignant melanoma, examination of eye and ear). The risk of death after SARS-CoV2 infection was lower in the vaccinated cohort, as was the risk of death after acute myocardia
背景:有关 SARS-CoV-2 疫苗有效性的观察性研究很容易受到混杂因素的影响,阴性对照方法可以说明这一点:全国范围内基于人口的队列研究,包括两组年龄在 60-90 岁之间的丹麦居民,年龄和性别按 1:1 匹配:一个已接种疫苗队列和一个未接种疫苗队列,包括 2021 年 3 月 1 日至 7 月 1 日期间接种 SARS-CoV-2 疫苗的 61052 人和 2021 年 7 月 1 日之前未接种疫苗的 61052 人。在这两个队列中,我们建立了阴性对照队列,其中包括确诊为 SARS-CoV-2 感染或急性心肌梗死、中风、癌症、低能量骨折或头部外伤的患者。结果包括 SARS-CoV-2 感染、阴性对照结果(如乳房 X 光检查、前列腺活检、白内障手术、恶性黑色素瘤、眼部和耳部检查)和死亡。我们使用 Cox 回归计算调整后的发病率和死亡率比(aIRR 和 aMRR):结果:接种疫苗的人群感染 SARS-CoV2 的风险和所有阴性对照结果的风险都较高,眼部检查的 aIRR 为 1.15(95% CI:1.09- 1.21),恶性黑色素瘤的 aIRR 为 3.05(95% CI:2.24- 4.14)。相反,SARS-CoV-2感染队列和所有阴性对照队列中接种疫苗者的死亡风险较低,从SARS-CoV-2感染后的aMRR为0.23(95% CI:0.19- 0.26)到中风后的0.50(95% CI:0.37- 0.67)不等:我们的研究结果表明,SARS-CoV-2 疫苗有效性的观察性研究可能会受到大量混杂因素的影响。因此,在出现新的 SARS-CoV-2 变异株和推出多种加强型疫苗后,随机试验对于确定疫苗疗效至关重要:在SARS-CoV-2新变种出现和多种加强型SARS-CoV-2疫苗推出后,接种疫苗对SARS-CoV-2感染和感染后死亡风险的影响主要是在观察性研究中探讨的。我们采用了阴性对照方法来研究混杂因素是否会影响观察性 SARS-CoV-2 疫苗有效性研究的结果:我们利用 SARS-CoV-2 疫苗推广期间获得的丹麦登记数据,在全国范围内对 60-90 岁的丹麦居民进行了一项基于人群的匹配队列研究。与未接种疫苗的人相比,接种疫苗的人感染 SARS-CoV2 的风险增加了,但所有负面对照结果(乳房 X 光检查、前列腺活检、白内障手术、恶性黑色素瘤、眼部和耳部检查)的风险也增加了。接种疫苗的人群感染 SARS-CoV2 后死亡的风险较低,急性心肌梗死、中风、癌症、低能量骨折和头部外伤后死亡的风险也较低:阴性对照方法表明,SARS-CoV-2 疫苗有效性的观察性研究可能容易受到大量混杂因素的影响,从而影响观察到的关联。这种偏差既可能导致疫苗效果被低估(接种者感染 SARS-CoV2 的风险增加),也可能导致疫苗效果被高估(接种者感染 SARS-CoV2 后死亡的风险降低)。我们的研究结果突出表明,在出现新的 SARS-CoV-2 变体和推出多种加强型疫苗后,有必要进行随机疫苗效力研究。
{"title":"Confounding and Negative Control Methods in Observational Study of SARS-CoV-2 Vaccine Effectiveness: A Nationwide, Population-Based Danish Health Registry Study","authors":"Niels Obel, Matthew P Fox, Malte M Tetens, Lars Pedersen, Tyra Grove Krause, Henrik Ullum, Henrik Toft Sørensen","doi":"10.2147/clep.s468572","DOIUrl":"https://doi.org/10.2147/clep.s468572","url":null,"abstract":"&lt;strong&gt;Background:&lt;/strong&gt; Observational studies of SARS-CoV-2 vaccine effectiveness are prone to confounding, which can be illustrated using negative control methods.&lt;br/&gt;&lt;strong&gt;Methods:&lt;/strong&gt; Nationwide population-based cohort study including two cohorts of Danish residents 60– 90 years of age matched 1:1 on age and sex: A vaccinated and a non-vaccinated cohort, including 61052 SARS-CoV-2 vaccinated individuals between 1 March and 1 July 2021 and 61052 individuals not vaccinated preceding 1 July 2021. From these two cohorts, we constructed negative control cohorts of individuals diagnosed with SARS-CoV-2 infection or acute myocardial infarction, stroke, cancer, low energy fracture, or head-trauma. Outcomes were SARS-CoV-2 infection, negative control outcomes (eg, mammography, prostate biopsy, operation for cataract, malignant melanoma, examination of eye and ear), and death. We used Cox regression to calculate adjusted incidence and mortality rate ratios (aIRR and aMRR).&lt;br/&gt;&lt;strong&gt;Results:&lt;/strong&gt; Risks of SARS-CoV2 infection and all negative control outcomes were elevated in the vaccinated population, ranging from an aIRR of 1.15 (95% CI: 1.09– 1.21) for eye examinations to 3.05 (95% CI: 2.24– 4.14) for malignant melanoma. Conversely, the risk of death in the SARS-CoV-2 infected cohort and in all negative control cohorts was lower in vaccinated individuals, ranging from an aMRR of 0.23 (95% CI: 0.19– 0.26) after SARS-CoV-2 infection to 0.50 (95% CI: 0.37– 0.67) after stroke.&lt;br/&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; Our findings indicate that observational studies of SARS-CoV-2 vaccine effectiveness may be subject to substantial confounding. Therefore, randomized trials are essential to establish vaccine efficacy after the emergence of new SARS-CoV-2 variants and the rollout of multiple booster vaccines.&lt;br/&gt;&lt;br/&gt;&lt;strong&gt;Plain Language Summary:&lt;/strong&gt; &lt;strong&gt;Why was this study done&lt;/strong&gt;: After the emergence of new SARS-CoV-2 variants and the rollout of multiple booster SARS-CoV-2 vaccines, the impact of vaccination on risk of SARS-CoV-2 infection and death after the infection has mainly been explored in observational studies. We used negative control methods to investigate whether confounding affects the results of observational SARS-CoV-2 vaccine effectiveness studies.&lt;br/&gt;&lt;strong&gt;Findings&lt;/strong&gt;: We used Danish registry data obtained during the SARS-CoV-2 vaccine roll-out to conduct a nationwide, matched population-based cohort study of Danish residents 60– 90 years in which we compared vaccinated individuals with non-vaccinated individuals. Compared with unvaccinated individuals, vaccinated individuals had increased risks of SARS-CoV2 infection but also had increased risks of all negative control outcomes (mammography, prostate biopsy, operation for cataract, malignant melanoma, examination of eye and ear). The risk of death after SARS-CoV2 infection was lower in the vaccinated cohort, as was the risk of death after acute myocardia","PeriodicalId":10362,"journal":{"name":"Clinical Epidemiology","volume":"1 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141776906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of Second Primary Cancer Among Patients with Cardio-Esophageal Cancer in Finland: A Nationwide Population-Based Study 芬兰心食管癌患者罹患第二原发性癌症的风险:一项基于全国人口的研究
IF 3.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-07-22 DOI: 10.2147/clep.s471802
Rayan Nikkilä, Elli Hirvonen, Janne Pitkäniemi, Jari V Räsänen, Nea K Malila, Antti Mäkitie
Purpose: The occurrence of a second primary cancer (SPC) after primary esophageal carcinoma (EC) or gastric cardia carcinoma(GCC) is well acknowledged. However, previous research on the risk of SPC among these patients has been predominantly conducted in Asian countries. Yet, notable population-dependent variation in histological types and risk profiles exists. This register-based study assesses the histology-specific risk of SPC among individuals initially diagnosed with a first primary EC or GCC.
Patients and Methods: We obtained data on 7197 patients diagnosed with EC/GCC in Finland between 1980 and 2022 from the Finnish Cancer Registry. Standardized incidence ratios (SIR) of SPC were subsequently calculated relatively to the cancer risk of the general population.
Results: The average and median follow-up times were 2.8 years and 10.5 months. Adenocarcinomas and squamous cell carcinomas comprised 57.8% (n = 4165) and 36.6% (n = 2631) of all cases, respectively. An increased SIR was noted among EC/GCC patients after 15– 20 years of follow-up (SIR 1.49, 95% CI: 1.01– 2.11). Among adenocarcinoma patients, an increased SIR for SPCs of the digestive organs was seen in the 40– 54-year-old group (SIR 9.86, 95% CI: 3.62– 21.45). Squamous cell carcinoma patients displayed increased SIRs for cancer of the mouth/pharynx (SIR 3.20, 95% CI: 1.17– 6.95) and respiratory organs (1.77, 1.07– 2.76).
Conclusion: Healthcare professionals should be aware of the increased risk of SPCs occurring in the mouth/pharynx, respiratory and digestive organs in survivors of EC/GCC. Patients should be advised about this risk and remain alert for symptoms, even beyond the standard 5-year follow-up period.

Keywords: esophageal squamous cell carcinoma, adenocarcinoma, gastric cardia carcinoma, tumor, second primary cancer
目的:在原发性食管癌(EC)或胃贲门癌(GCC)之后发生第二原发性癌症(SPC)已得到广泛认可。然而,以往有关这些患者罹患 SPC 风险的研究主要在亚洲国家进行。然而,组织学类型和风险特征存在显著的人口依赖性差异。这项以登记为基础的研究评估了初次诊断为原发性EC或GCC患者中SPC的组织学特异性风险:我们从芬兰癌症登记处获得了1980年至2022年间芬兰7197名确诊为EC/GCC患者的数据。随后计算了相对于普通人群癌症风险的SPC标准化发病率(SIR):平均和中位随访时间分别为 2.8 年和 10.5 个月。腺癌和鳞状细胞癌分别占所有病例的 57.8%(n = 4165)和 36.6%(n = 2631)。在随访15-20年后,EC/GCC患者的SIR有所上升(SIR为1.49,95% CI:1.01-2.11)。在腺癌患者中,40-54 岁组消化器官 SPC 的 SIR 值升高(SIR 值为 9.86,95% CI:3.62-21.45)。鳞状细胞癌患者口腔/咽部癌症(SIR:3.20,95% CI:1.17-6.95)和呼吸器官癌症(SIR:1.77,1.07-2.76)的SIR均有所增加:医护人员应认识到,EC/GCC幸存者的口腔/咽部、呼吸器官和消化器官发生SPC的风险增加。关键词:食管鳞状细胞癌、腺癌、胃贲门癌、肿瘤、第二原发癌
{"title":"Risk of Second Primary Cancer Among Patients with Cardio-Esophageal Cancer in Finland: A Nationwide Population-Based Study","authors":"Rayan Nikkilä, Elli Hirvonen, Janne Pitkäniemi, Jari V Räsänen, Nea K Malila, Antti Mäkitie","doi":"10.2147/clep.s471802","DOIUrl":"https://doi.org/10.2147/clep.s471802","url":null,"abstract":"<strong>Purpose:</strong> The occurrence of a second primary cancer (SPC) after primary esophageal carcinoma (EC) or gastric cardia carcinoma(GCC) is well acknowledged. However, previous research on the risk of SPC among these patients has been predominantly conducted in Asian countries. Yet, notable population-dependent variation in histological types and risk profiles exists. This register-based study assesses the histology-specific risk of SPC among individuals initially diagnosed with a first primary EC or GCC.<br/><strong>Patients and Methods:</strong> We obtained data on 7197 patients diagnosed with EC/GCC in Finland between 1980 and 2022 from the Finnish Cancer Registry. Standardized incidence ratios (SIR) of SPC were subsequently calculated relatively to the cancer risk of the general population.<br/><strong>Results:</strong> The average and median follow-up times were 2.8 years and 10.5 months. Adenocarcinomas and squamous cell carcinomas comprised 57.8% (n = 4165) and 36.6% (n = 2631) of all cases, respectively. An increased SIR was noted among EC/GCC patients after 15– 20 years of follow-up (SIR 1.49, 95% CI: 1.01– 2.11). Among adenocarcinoma patients, an increased SIR for SPCs of the digestive organs was seen in the 40– 54-year-old group (SIR 9.86, 95% CI: 3.62– 21.45). Squamous cell carcinoma patients displayed increased SIRs for cancer of the mouth/pharynx (SIR 3.20, 95% CI: 1.17– 6.95) and respiratory organs (1.77, 1.07– 2.76).<br/><strong>Conclusion:</strong> Healthcare professionals should be aware of the increased risk of SPCs occurring in the mouth/pharynx, respiratory and digestive organs in survivors of EC/GCC. Patients should be advised about this risk and remain alert for symptoms, even beyond the standard 5-year follow-up period.<br/><br/><strong>Keywords:</strong> esophageal squamous cell carcinoma, adenocarcinoma, gastric cardia carcinoma, tumor, second primary cancer<br/>","PeriodicalId":10362,"journal":{"name":"Clinical Epidemiology","volume":"24 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141745865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Characteristics and Outcomes of Hospitalized Chronic Kidney Disease Patients with and without Type 2 Diabetes Mellitus: Observations from the German Claims Data-Based Cohort of the CaReMe-CKD Multinational Study 患有和未患有 2 型糖尿病的住院慢性肾病患者的患者特征和疗效:基于德国索赔数据的 CaReMe-CKD 跨国研究队列观察结果
IF 3.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-07-22 DOI: 10.2147/clep.s459767
Johannes Leiner, Vincent Pellissier, Sebastian König, Lars Stellmacher, Sven Hohenstein, Carolin Schanner, Stefan Kwast, Ralf Kuhlen, Andreas Bollmann
Introduction: Type 2 diabetes mellitus (T2DM) is a leading cause of chronic kidney disease (CKD) globally. Both conditions substantially worsen patients’ prognosis. Current data on German in-hospital CKD cohorts are scarce. The multinational CaReMe study was initiated to evaluate the current epidemiology and healthcare burden of cardiovascular, renal and metabolic diseases. In this substudy, we share real-world data on CKD inpatients stratified for coexisting T2DM derived from a large German hospital network.
Methods: This study used administrative data of inpatient cases from 89 Helios hospitals from 01/01/2016 to 28/02/2022. Data were extracted from ICD-10-encoded discharge diagnoses and OPS-encoded procedures. The first case meeting a previously developed CKD definition (defined by ICD-10- and OPS-codes) was considered the index case for a particular patient. Subsequent hospitalizations were analysed for readmission statistics. Patient characteristics and pre-defined endpoints were stratified for T2DM at index case.
Results: In total, 48,011 patients with CKD were included in the present analysis (mean age ± standard deviation, 73.8 ± 13.1 years; female, 44%) of whom 47.9% had co-existing T2DM. Patients with T2DM were older (75 ± 10.6 vs 72.7 ± 14.9 years, p < 0.001), but gender distribution was similar to patients without T2DM. The burden of cardiovascular disease was increased in patients with T2DM, and index and follow-up in-hospital mortality rates were higher. Non-T2DM patients were characterised by more advanced CKD at baseline. Patients with T2DM had consistently higher readmission numbers for all events of interest, except for readmissions due to kidney failure/dialysis, which were more common in non-T2DM patients.
Conclusion: In this study, we present recent data on hospitalized patients with CKD in Germany. In this CKD cohort, nearly half had T2DM, which substantially affected cardiovascular disease burden, rehospitalization frequency and mortality. Interestingly, non-diabetic patients had more advanced underlying renal disease, which affected renal outcomes.

Keywords: chronic kidney disease, type 2 diabetes mellitus, administrative data, in-hospital mortality, kidney failure, rehospitalization
导言:2 型糖尿病(T2DM)是全球慢性肾脏病(CKD)的主要病因。这两种疾病都会严重恶化患者的预后。目前有关德国院内 CKD 队列的数据很少。跨国 CaReMe 研究旨在评估当前心血管、肾脏和代谢性疾病的流行病学和医疗负担。在这项子研究中,我们分享了来自德国一家大型医院网络的 CKD 住院病人的真实数据,这些数据根据并存的 T2DM 进行了分层:本研究使用了89家Helios医院从2016年1月1日至2022年2月28日的住院病例管理数据。数据提取自ICD-10编码的出院诊断和OPS编码的手术。符合先前制定的 CKD 定义(由 ICD-10 和 OPS 编码定义)的首个病例被视为特定患者的索引病例。随后的住院病例将进行再入院统计分析。根据指标病例中的 T2DM 对患者特征和预设终点进行分层:本分析共纳入 48 011 名慢性肾脏病患者(平均年龄为 73.8 ± 13.1 岁;女性占 44%),其中 47.9% 的患者同时患有 T2DM。患有 T2DM 的患者年龄较大(75 ± 10.6 岁 vs 72.7 ± 14.9 岁,p < 0.001),但性别分布与未患有 T2DM 的患者相似。T2DM患者的心血管疾病负担加重,指数和随访院内死亡率较高。非T2DM患者基线时的慢性肾功能衰竭程度更高。除了肾衰竭/透析导致的再入院在非T2DM患者中更为常见外,T2DM患者在所有相关事件中的再入院率一直较高:在这项研究中,我们提供了德国慢性肾脏病住院患者的最新数据。在这组慢性肾脏病患者中,近半数患有 T2DM,这严重影响了心血管疾病负担、再住院频率和死亡率。有趣的是,非糖尿病患者的潜在肾脏疾病更为严重,这也影响了肾脏疾病的治疗效果。关键词:慢性肾脏病、2 型糖尿病、管理数据、院内死亡率、肾衰竭、再住院率
{"title":"Patient Characteristics and Outcomes of Hospitalized Chronic Kidney Disease Patients with and without Type 2 Diabetes Mellitus: Observations from the German Claims Data-Based Cohort of the CaReMe-CKD Multinational Study","authors":"Johannes Leiner, Vincent Pellissier, Sebastian König, Lars Stellmacher, Sven Hohenstein, Carolin Schanner, Stefan Kwast, Ralf Kuhlen, Andreas Bollmann","doi":"10.2147/clep.s459767","DOIUrl":"https://doi.org/10.2147/clep.s459767","url":null,"abstract":"<strong>Introduction:</strong> Type 2 diabetes mellitus (T2DM) is a leading cause of chronic kidney disease (CKD) globally. Both conditions substantially worsen patients’ prognosis. Current data on German in-hospital CKD cohorts are scarce. The multinational CaReMe study was initiated to evaluate the current epidemiology and healthcare burden of cardiovascular, renal and metabolic diseases. In this substudy, we share real-world data on CKD inpatients stratified for coexisting T2DM derived from a large German hospital network.<br/><strong>Methods:</strong> This study used administrative data of inpatient cases from 89 Helios hospitals from 01/01/2016 to 28/02/2022. Data were extracted from ICD-10-encoded discharge diagnoses and OPS-encoded procedures. The first case meeting a previously developed CKD definition (defined by ICD-10- and OPS-codes) was considered the index case for a particular patient. Subsequent hospitalizations were analysed for readmission statistics. Patient characteristics and pre-defined endpoints were stratified for T2DM at index case.<br/><strong>Results:</strong> In total, 48,011 patients with CKD were included in the present analysis (mean age ± standard deviation, 73.8 ± 13.1 years; female, 44%) of whom 47.9% had co-existing T2DM. Patients with T2DM were older (75 ± 10.6 vs 72.7 ± 14.9 years, p &lt; 0.001), but gender distribution was similar to patients without T2DM. The burden of cardiovascular disease was increased in patients with T2DM, and index and follow-up in-hospital mortality rates were higher. Non-T2DM patients were characterised by more advanced CKD at baseline. Patients with T2DM had consistently higher readmission numbers for all events of interest, except for readmissions due to kidney failure/dialysis, which were more common in non-T2DM patients.<br/><strong>Conclusion:</strong> In this study, we present recent data on hospitalized patients with CKD in Germany. In this CKD cohort, nearly half had T2DM, which substantially affected cardiovascular disease burden, rehospitalization frequency and mortality. Interestingly, non-diabetic patients had more advanced underlying renal disease, which affected renal outcomes. <br/><br/><strong>Keywords:</strong> chronic kidney disease, type 2 diabetes mellitus, administrative data, in-hospital mortality, kidney failure, rehospitalization<br/>","PeriodicalId":10362,"journal":{"name":"Clinical Epidemiology","volume":"44 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141745868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimation of Personal Symptom Networks Using the Ising Model for Adult Survivors of Childhood Cancer: A Simulation Study with Real-World Data Application 使用伊辛模型估计儿童癌症成年幸存者的个人症状网络:真实世界数据应用模拟研究
IF 3.9 2区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-07-17 DOI: 10.2147/clep.s464104
Yiwang Zhou, Madeline R Horan, Samira Deshpande, Kirsten K Ness, Melissa M Hudson, I-Chan Huang, Deokumar Srivastava
Purpose: Childhood cancer survivors experience interconnected symptoms, patterns of which can be elucidated by network analysis. However, current symptom networks are constructed based on the average survivors without considering individual heterogeneities. We propose to evaluate personal symptom network estimation using the Ising model with covariates through simulations and estimate personal symptom network for adult childhood cancer survivors.
Patients and Methods: We adopted the Ising model with covariates to construct networks by employing logistic regressions for estimating associations between binary symptoms. Simulation experiments assessed the robustness of this method in constructing personal symptom network. Real-world data illustration included 1708 adult childhood cancer survivors from the St. Jude Lifetime Cohort Study (SJLIFE), a retrospective cohort study with prospective follow-up to characterize the etiology and late effects for childhood cancer survivors. Patients’ baseline symptoms in 10 domains (cardiac, pulmonary, sensation, nausea, movement, pain, memory, fatigue, anxiety, depression) and individual characteristics (age, sex, race/ethnicity, attained education, personal income, and marital status) were self-reported using survey. Treatment variables (any chemo or radiation therapy) were obtained from medical records. Personal symptom network of 10 domains was estimated using the Ising model, incorporating individual characteristics and treatment data.
Results: Simulations confirmed the robustness of the Ising model with covariates in constructing personal symptom networks. Real-world data analysis identified age, sex, race/ethnicity, education, marital status, and treatment (any chemo and radiation therapy) as major factors influencing symptom co-occurrence. Older childhood cancer survivors showed stronger cardiac-fatigue associations. Survivors of racial/ethnic minorities had stronger pain-fatigue associations. Female survivors with above-college education demonstrated stronger pain-anxiety associations. Unmarried survivors who received radiation had stronger association between movement and memory problems.
Conclusion: The Ising model with covariates accurately estimates personal symptom networks. Individual heterogeneities exist in symptom co-occurrence patterns for childhood cancer survivors. The estimated personal symptom network offers insights into interconnected symptom experiences.

Keywords: bootstrap testing, individual heterogeneity, Ising model, network analysis, sociodemographic
目的:儿童癌症幸存者会出现相互关联的症状,这些症状的模式可通过网络分析加以阐明。然而,目前的症状网络是根据幸存者的平均水平构建的,没有考虑个体的异质性。我们建议通过模拟评估使用带有协变量的 Ising 模型估计个人症状网络,并估计成年儿童癌症幸存者的个人症状网络:我们采用了带有协变量的 Ising 模型,通过逻辑回归估算二元症状之间的关联来构建网络。模拟实验评估了这种方法在构建个人症状网络时的稳健性。真实世界的数据说明包括圣裘德终生队列研究(SJLIFE)中的1708名成年儿童癌症幸存者,该研究是一项具有前瞻性随访的回顾性队列研究,旨在描述儿童癌症幸存者的病因和晚期影响。患者在 10 个方面(心脏、肺部、感觉、恶心、运动、疼痛、记忆、疲劳、焦虑、抑郁)的基线症状和个人特征(年龄、性别、种族/民族、受教育程度、个人收入和婚姻状况)均通过调查进行自我报告。治疗变量(化疗或放疗)来自医疗记录。利用伊辛模型,结合个人特征和治疗数据,估算出了 10 个领域的个人症状网络:结果:模拟证实了伊辛模型在构建个人症状网络时的稳健性。真实世界的数据分析表明,年龄、性别、种族/民族、教育程度、婚姻状况和治疗(任何化疗和放疗)是影响症状共同发生的主要因素。年龄较大的儿童癌症幸存者表现出更强的心因性疲劳关联。少数种族/族裔幸存者的疼痛-疲劳关联性更强。受过大学以上教育的女性幸存者表现出更强的疼痛-焦虑关联。接受过放射治疗的未婚幸存者在运动和记忆问题之间有更强的关联:结论:带有协变量的 Ising 模型能准确估计个人症状网络。儿童癌症幸存者的症状共现模式存在个体异质性。估计的个人症状网络有助于深入了解相互关联的症状体验。
{"title":"Estimation of Personal Symptom Networks Using the Ising Model for Adult Survivors of Childhood Cancer: A Simulation Study with Real-World Data Application","authors":"Yiwang Zhou, Madeline R Horan, Samira Deshpande, Kirsten K Ness, Melissa M Hudson, I-Chan Huang, Deokumar Srivastava","doi":"10.2147/clep.s464104","DOIUrl":"https://doi.org/10.2147/clep.s464104","url":null,"abstract":"<strong>Purpose:</strong> Childhood cancer survivors experience interconnected symptoms, patterns of which can be elucidated by network analysis. However, current symptom networks are constructed based on the average survivors without considering individual heterogeneities. We propose to evaluate personal symptom network estimation using the Ising model with covariates through simulations and estimate personal symptom network for adult childhood cancer survivors.<br/><strong>Patients and Methods:</strong> We adopted the Ising model with covariates to construct networks by employing logistic regressions for estimating associations between binary symptoms. Simulation experiments assessed the robustness of this method in constructing personal symptom network. Real-world data illustration included 1708 adult childhood cancer survivors from the St. Jude Lifetime Cohort Study (SJLIFE), a retrospective cohort study with prospective follow-up to characterize the etiology and late effects for childhood cancer survivors. Patients’ baseline symptoms in 10 domains (cardiac, pulmonary, sensation, nausea, movement, pain, memory, fatigue, anxiety, depression) and individual characteristics (age, sex, race/ethnicity, attained education, personal income, and marital status) were self-reported using survey. Treatment variables (any chemo or radiation therapy) were obtained from medical records. Personal symptom network of 10 domains was estimated using the Ising model, incorporating individual characteristics and treatment data.<br/><strong>Results:</strong> Simulations confirmed the robustness of the Ising model with covariates in constructing personal symptom networks. Real-world data analysis identified age, sex, race/ethnicity, education, marital status, and treatment (any chemo and radiation therapy) as major factors influencing symptom co-occurrence. Older childhood cancer survivors showed stronger cardiac-fatigue associations. Survivors of racial/ethnic minorities had stronger pain-fatigue associations. Female survivors with above-college education demonstrated stronger pain-anxiety associations. Unmarried survivors who received radiation had stronger association between movement and memory problems.<br/><strong>Conclusion:</strong> The Ising model with covariates accurately estimates personal symptom networks. Individual heterogeneities exist in symptom co-occurrence patterns for childhood cancer survivors. The estimated personal symptom network offers insights into interconnected symptom experiences.<br/><br/><strong>Keywords:</strong> bootstrap testing, individual heterogeneity, Ising model, network analysis, sociodemographic<br/>","PeriodicalId":10362,"journal":{"name":"Clinical Epidemiology","volume":"9 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141718277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Epidemiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1